Neurotrophin therapy and cochlear implantation: Translating animal models to human therapy

Experimental Neurology

Volumn 226, Issue 1, 2010, Pages 1-5

  Staecker, Hinrich ^a   Garnham, Carolyn ^b  

^a UNIVERSITY OF KANSAS   (United States)

^b MED EL GmbH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; PARVOVIRUS VECTOR; NERVE GROWTH FACTOR;

AUDITORY BRAIN STEM IMPLANT; AUDITORY STIMULATION; AUDITORY SYSTEM FUNCTION; CELL BASED GENE THERAPY; CELL SURVIVAL; FUNCTIONAL ELECTRICAL STIMULATION; GENE THERAPY; GENETIC TRANSDUCTION; HAIR CELL; HEARING IMPAIRMENT; HUMAN; IMPLANTATION; NERVE DEGENERATION; NERVE FIBER GROWTH; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SPIRAL GANGLION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CHEMICALLY INDUCED; COCHLEAR IMPLANTATION; CYTOLOGY; DEAFNESS; DISEASE MODEL; DRUG EFFECTS; NERVE CELL; TRANSLATIONAL RESEARCH;

ANIMALS; CELL SURVIVAL; COCHLEAR IMPLANTATION; DEAFNESS; DISEASE MODELS, ANIMAL; GENE THERAPY; HAIR CELLS, VESTIBULAR; HUMANS; NERVE GROWTH FACTORS; NEURONS; SPIRAL GANGLION; TRANSLATIONAL RESEARCH; GENETIC THERAPY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 77957815188     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.07.012     Document Type: Note

References (65)

1. Adamson C.L., Reid M.A., Davis R.L. Opposite actions of brain-derived neurotrophic factor and neurotrophin-3 on firing features and ion channel composition of murine spiral ganglion neurons. J. Neurosci. 2002, 22:1385-1396.
2. Agterberg M.J., Versnel H., van Dijk L.M., de Groot J.C., Klis S.F. Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs. J. Assoc. Res. Otolaryngol. 2009, 10:355-367.
3. Bankiewicz K.S., Forsayeth J., Eberling J.L., Sanchez-Pernaute R., Pivirotto P., Bringas J., Herscovitch P., Carson R.E., Eckelman W., Reutter B., Cunningham J. Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. Mol. Ther. 2006, 14:564-570.
4. Bichler E., Spoendlin H., Rauchegger H. Degeneration of cochlear neurons after amikacin intoxication in the rat. Arch. Otorhinolaryngol. 1983, 237:201-208.
5. Bierer J.A., Faulkner K.F. Identifying cochlear implant channels with poor electrode-neuron interface: partial tripolar, single-channel thresholds and psychophysical tuning curves. Ear Hear. 2010, 31:247-258.
6. Botros A., Psarros C. Neural response telemetry reconsidered: II. The influence of neural population on the ecap recovery function and refractoriness. Ear Hear. 2010.
7. Bowers W.J., Chen X., Guo H., Frisina D.R., Federoff H.J., Frisina R.D. Neurotrophin-3 transduction attenuates cisplatin spiral ganglion neuron ototoxicity in the cochlea. Mol. Ther. 2002, 6:12-18.
8. Briaire J.J., Frijns J.H. The consequences of neural degeneration regarding optimal cochlear implant position in scala tympani: a model approach. Hear. Res. 2006, 214:17-27.
9. Brill S., Muller J., Hagen R., Moltner A., Brockmeier S.J., Stark T., Helbig S., Maurer J., Zahnert T., Zierhofer C., Nopp P., Anderson I., Strahl S. Site of cochlear stimulation and its effect on electrically evoked compound action potentials using the MED-EL standard electrode array. Biomed. Eng. Online 2009, 8:40.
10. Burton E.A., Fink D.J., Glorioso J.C. Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications. Curr. Opin. Mol. Ther. 2005, 7:326-336.
11. Chen X., Frisina R.D., Bowers W.J., Frisina D.R., Federoff H.J. HSV amplicon-mediated neurotrophin-3 expression protects murine spiral ganglion neurons from cisplatin-induced damage. Mol. Ther. 2001, 3:958-963.
12. Chen X.W., Li H., Cao K.L., Wei C.G., Jin X. The transduction of neurotrophin-3/GDNF attenuates the SGNC damage in deaf mice. Zhonghua Yi Xue Za Zhi 2003, 83:1517-1520.
13. Chikar J.A., Colesa D.J., Swiderski D.L., Di Polo A., Raphael Y., Pfingst B.E. Over-expression of BDNF by adenovirus with concurrent electrical stimulation improves cochlear implant thresholds and survival of auditory neurons. Hear. Res. 2008, 245:24-34.
14. Colletti V., Shannon R.V. Open set speech perception with auditory brainstem implant?. Laryngoscope 2005, 115:1974-1978.
15. Evans A.J., Thompson B.C., Wallace G.G., Millard R., O'Leary S.J., Clark G.M., Shepherd R.K., Richardson R.T. Promoting neurite outgrowth from spiral ganglion neuron explants using polypyrrole/BDNF-coated electrodes. J. Biomed. Mater. Res. A 2009, 91:241-250.
16. Farinas I., Jones K.R., Tessarollo L., Vigers A.J., Huang E., Kirstein M., de Caprona D.C., Coppola V., Backus C., Reichardt L.F., Fritzsch B. Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression. J. Neurosci. 2001, 21:6170-6180.
17. Fayad J.N., Linthicum F.H. Multichannel cochlear implants: relation of histopathology to performance. Laryngoscope 2006, 116:1310-1320.
18. Fritzsch B., Barbacid M., Silos-Santiago I. The combined effects of trkB and trkC mutations on the innervation of the inner ear. Int. J. Dev. Neurosci. 1998, 16:493-505.
19. Fu Q.J. Temporal processing and speech recognition in cochlear implant users. NeuroReport 2002, 13:1635-1639.
20. Garnham C., Reetz G., Jolly C., Miller J., Salt A., Beal F. Drug delivery to the cochlea after implantation: consideration of the risk factors. Cochlear Implants Int. 2005, 6(Suppl 1):12-14.
21. Geschwind M.D., Hartnick C.J., Liu W., Amat J., Van De Water T.R., Federoff H.J. Defective HSV-1 vector expressing BDNF in auditory ganglia elicits neurite outgrowth: model for treatment of neuron loss following cochlear degeneration. Hum. Gene Ther. 1996, 7:173-182.
22. Hansen M.R., Zha X.M., Bok J., Green S.H. Multiple distinct signal pathways, including an autocrine neurotrophic mechanism, contribute to the survival-promoting effect of depolarization on spiral ganglion neurons in vitro. J. Neurosci. 2001, 21:2256-2267.
23. Hartmann R., Topp G., Klinke R. Discharge patterns of cat primary auditory fibers with electrical stimulation of the cochlea. Hear. Res. 1984, 13:47-62.
24. Hossain W.A., Brumwell C.L., Morest D.K. Sequential interactions of fibroblast growth factor-2, brain-derived neurotrophic factor, neurotrophin-3, and their receptors define critical periods in the development of cochlear ganglion cells. Exp. Neurol. 2002, 175:138-151.
25. Hossain W.A., D'Sa C., Morest D.K. Interactive roles of fibroblast growth factor 2 and neurotrophin 3 in the sequence of migration, process outgrowth, and axonal differentiation of mouse cochlear ganglion cells. J. Neurosci. Res. 2008, 86:2376-2391.
26. Hughes M.L., Abbas P.J. The relation between electrophysiologic channel interaction and electrode pitch ranking in cochlear implant recipients. J. Acoust. Soc. Am. 2006, 119:1527-1537.
27. Jolly C., Garnham C., Mirzadeh H., Truy E., Martini A., Kiefer J., Braun S. Electrode features for hearing preservation and drug delivery strategies. Adv. Otorhinolaryngol. 2010, 67:28-42.
28. Kanzaki S., Stover T., Kawamoto K., Prieskorn D.M., Altschuler R.A., Miller J.M., Raphael Y. Glial cell line-derived neurotrophic factor and chronic electrical stimulation prevent VIII cranial nerve degeneration following denervation. J. Comp. Neurol. 2002/12/16, 454:350-360.
29. Khan A.M., Handzel O., Burgess B.J., Damian D., Eddington D.K., Nadol J.B. Is word recognition correlated with the number of surviving spiral ganglion cells and electrode insertion depth in human subjects with cochlear implants?. Laryngoscope 2005/4, 115:672-677.
30. Khan A.M., Handzel O., Damian D., Eddington D.K., Nadol J.B. Effect of cochlear implantation on residual spiral ganglion cell count as determined by comparison with the contralateral nonimplanted inner ear in humans. Ann. Otol. Rhinol. Laryngol. 2005/5, 114:381-385.
31. Khan A.M., Whiten D.M., Nadol J.B., Eddington D.K. Histopathology of human cochlear implants: correlation of psychophysical and anatomical measures. Hear. Res. 2005/7, 205:83-93.
32. Leake P.A., Hradek G.T., Snyder R.L. Chronic electrical stimulation by a cochlear implant promotes survival of spiral ganglion neurons after neonatal deafness. J. Comp. Neurol. 1999, 412:543-562.
33. Leake P.A., Hradek G.T., Vollmer M., Rebscher S.J. Neurotrophic effects of GM1 ganglioside and electrical stimulation on cochlear spiral ganglion neurons in cats deafened as neonates. J. Comp. Neurol. 2007, 501:837-853.
34. Linthicum F.H., Fayad J.N. Spiral ganglion cell loss is unrelated to segmental cochlear sensory system degeneration in humans. Otol. Neurotol. 2009, 30:418-422.
35. McKay C.M., McDermott H.J. The perceptual effects of current pulse duration in electrical stimulation of the auditory nerve. J. Acoust. Soc. Am. 1999, 106:998-1009.
36. Miller C.A., Faulkner M.J., Pfingst B.E. Functional responses from guinea pigs with cochlear implants. II. Changes in electrophysiological and psychophysical measures over time. Hear. Res. 1995, 92:100-111.
37. Miller C.A., Woodruff K.E., Pfingst B.E. Functional responses from guinea pigs with cochlear implants. I. Electrophysiological and psychophysical measures. Hear. Res. 1995, 92:85-99.
38. Miller J.M., Le Prell C.G., Prieskorn D.M., Wys N.L., Altschuler R.A. Delayed neurotrophin treatment following deafness rescues spiral ganglion cells from death and promotes regrowth of auditory nerve peripheral processes: effects of brain-derived neurotrophic factor and fibroblast growth factor. J. Neurosci. Res. 2007, 85:1959-1969.
39. Müller-Deile J., Hung T.-V., Morsnowski A., Charasse B., Matthijs K., von Wallenberg E., et al. 17th-22nd August 2003. Proceedings of the 2003 Conference on Implantable Auditory Prostheses 2003, 88. Asilomar, CA, August 2003.
40. Nadol J.B., Eddington D.K. Histopathology of the inner ear relevant to cochlear implantation. Adv. Otorhinolaryngol. 2006, 64:31-49.
41. Nakaizumi T., Kawamoto K., Minoda R., Raphael Y. Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol. Neurootol. 2004/5, 9:135-143.
42. O'Leary S.J., Richardson R.R., McDermott H.J. Principles of design and biological approaches for improving the selectivity of cochlear implant electrodes. J. Neural Eng. 2009, 6:055002.
43. Pauwels K., Gijsbers R., Toelen J., Schambach A., Willard-Gallo K., Verheust C., Debyser Z., Herman P. State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations. Curr. Gene Ther. 2009, 9:459-474.
44. Pettingill L.N., Minter R.L., Shepherd R.K. Schwann cells genetically modified to express neurotrophins promote spiral ganglion neuron survival in vitro. Neuroscience 2008, 152:821-828.
45. Pfingst B.E., Xu L., Thompson C.S. Across-site threshold variation in cochlear implants: relation to speech recognition. Audiol. Neurootol. 2004, 9:341-352.
46. Prado-Guitierrez P., Fewster L.M., Heasman J.M., McKay C.M., Shepherd R.K. Effect of interphase gap and pulse duration on electrically evoked potentials is correlated with auditory nerve survival. Hear. Res. 2006, 215:47-55.
47. Richardson R.T., Noushi F., O'Leary S. Inner ear therapy for neural preservation. Audiol. Neurootol. 2006, 11:343-356.
48. Roehm P.C., Hansen M.R. Strategies to preserve or regenerate spiral ganglion neurons. Curr. Opin. Otolaryngol. Head Neck Surg. 2005/10, 13:294-300.
49. Rubel E.W., Fritzsch B. Auditory system development: primary auditory neurons and their targets. Annu. Rev. Neurosci. 2002, 25:51-101.
50. Scheper V., Paasche G., Miller J.M., Warnecke A., Berkingali N., Lenarz T., Stover T. Effects of delayed treatment with combined GDNF and continuous electrical stimulation on spiral ganglion cell survival in deafened guinea pigs. J. Neurosci. Res. 2009, 87:1389-1399.
51. Shepherd R.K., Roberts L.A., Paolini A.G. Long-term sensorineural hearing loss induces functional changes in the rat auditory nerve. Eur. J. Neurosci. 2004, 20:3131-3140.
52. Shepherd R.K., Coco A., Epp S.B., Crook J.M. Chronic depolarization enhances the trophic effects of brain-derived neurotrophic factor in rescuing auditory neurons following a sensorineural hearing loss. J. Comp. Neurol. 2005, 486:145-158.
53. Shepherd R.K., Coco A., Epp S.B. Neurotrophins and electrical stimulation for protection and repair of spiral ganglion neurons following sensorineural hearing loss. Hear. Res. 2008, 242:100-109.
54. Shibata S.B., Cortez S.R., Beyer L.A., Wiler J.A., Di Polo A., Pfingst B.E., Raphael Y. Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleae. Exp. Neurol. 2010, 223:464-472.
55. Staecker H., Kopke R., Malgrange B., Lefebvre P., Van de Water T.R. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. NeuroReport 1996, 7:889-894.
56. Staecker H., Gabaizadeh R., Federoff H., Van De Water T.R. Brain-derived neurotrophic factor gene therapy prevents spiral ganglion degeneration after hair cell loss. Otolaryngol. Head Neck Surg. 1998, 119:7-13.
57. Staecker H., Jolly C., Garnham C. Cochlear implantation: an opportunity for drug development. Drug Discov. Today 2010, 15:314-321.
58. Stakhovskaya O., Hradek G.T., Snyder R.L., Leake P.A. Effects of age at onset of deafness and electrical stimulation on the developing cochlear nucleus in cats. Hear. Res. 2008, 243:69-77.
59. Stankovic K., Rio C., Xia A., Sugawara M., Adams J.C., Liberman M.C., Corfas G. Survival of adult spiral ganglion neurons requires erbB receptor signaling in the inner ear. J. Neurosci. 2004, 24:8651-8661.
60. Thompson B.C., Richardson R.T., Moulton S.E., Evans A.J., O'Leary S., Clark G.M., Wallace G.G. Conducting polymers, dual neurotrophins and pulsed electrical stimulation-dramatic effects on neurite outgrowth. J. Control. Release 2010, 141:161-167.
61. Vollmer M., Beitel R.E., Snyder R.L., Leake P.A. Spatial selectivity to intracochlear electrical stimulation in the inferior colliculus is degraded after long-term deafness in cats. J. Neurophysiol. 2007, 98:2588-2603.
62. Wise A.K., Hume C.R., Flynn B.O., Jeelall Y.S., Suhr C.L., Sgro B.E., O'Leary S.J., Shepherd R.K., Richardson R.T. Effects of Localized Neurotrophin Gene Expression on Spiral Ganglion Neuron Resprouting in the Deafened Cochlea. Mol. Ther. 2010.
63. Wissel K., Stover T., Hofmann N.S., Chernajovsky Y., Daly G., Sasse S., Warnecke A., Lenarz T., Gross G., Hoffmann A. Fibroblast-mediated delivery of GDNF induces neuronal-like outgrowth in PC12 cells. Otol. Neurotol. 2008, 29:475-481.
64. Zhou R., Abbas P.J., Assouline J.G. Electrically evoked auditory brainstem response in peripherally myelin-deficient mice. Hear. Res. 1995, 88:98-106.
65. Zhou Z., Liu Q., Davis R.L. Complex regulation of spiral ganglion neuron firing patterns by neurotrophin-3. J. Neurosci. 2005, 25:7558-7566.